
zzso zzso has been traditionally used for zzso during zzso zzso but more recently zzso zzso zzso is being used as an zzso zzso activity can be measured as a surrogate of zzso zzso We present 52 patients treated with zzso zzso on zzso confirming that fixed dosing is safe and zzso with sound zzso reason in relation to zzso zzso 

We undertook a prospective audit in a single dialysis zzso All patients were established on a simple zzso protocol for at least 1 month prior to the zzso Blood zzso activity was measured at time 0, 30, 60 and 120 zzso into and at the end of zzso zzso and safety data were collected on the study day and the two sessions before and after zzso 

zzso patients were included in the efficacy and safety analysis with 43 patients undergoing zzso analysis (9 sampling zzso Using current consensus (an zzso zzso activity of zzso zzso our zzso protocol resulted in satisfactory safety in all patients zzso Of 260 HD sessions, 10 zzso had reduced zzso zzso During 105 dialysis sessions (21 zzso using an zzso zzso 4 patients had one episode of minor bleeding and there were 6 episodes (2 zzso of zzso time greater than 15 zzso 

zzso administered zzso weekly as a fixed dose has good efficacy and is well tolerated as an zzso during HD when used according to our zzso 

